Virtual Panel Discussion: Practical Insights on Handling VUS
- Webinar | 25. 01. 14
From Ambiguity to Action: Practical Insights on Handling VUS
Understanding genetic variations and their implications is a cornerstone of advancing precision medicine. Yet, Variants of Uncertain Significance (VUS) remain a challenging gray area for clinicians and geneticists. How can we translate ambiguity into actionable insights for better patient care? To address these pressing questions, 3billion, Inc. is hosting a virtual panel discussion with some of Asia’s leading experts in genetics and genomic counseling.
Event Details
Date: Date: January 21, 2025
Time: 7:00 PM – 8:00 PM KST (UTC +9)
Location: Virtual (via Zoom)
Topic: From Ambiguity to Action: Practical Insights on Handling VUS
This event will bring together seasoned professionals from Asia to explore practical strategies for addressing VUS in clinical practice. Through shared experiences, expert insights, and interactive discussions, attendees will gain actionable knowledge to navigate the complexities of genomic uncertainty.
Moderator
From Ambiguity to Action: Practical Insights on Handling VUS
- Speaker
- Hane Lee Ph.D.
- Role
- Chief Genomics Officer (CGO) at 3billion
Meet Our Panelists
From Ambiguity to Action: Practical Insights on Handling VUS
- Speaker
- Dr. Cut Hafifah
- Role
- Pediatric Consultant
From Ambiguity to Action: Practical Insights on Handling VUS
- Speaker
- Dr. Leong Huey Yin
- Role
- Pediatrician and Clinical Geneticist
From Ambiguity to Action: Practical Insights on Handling VUS
- Speaker
- Sommon Klumsathian
- Role
- Genetic Counselor
From Ambiguity to Action: Practical Insights on Handling VUS
- Speaker
- Dr. GoHun Seo
- Role
- Chief Medical Officer
What to Expect
This panel will provide an interactive platform to:
- Understand the role of AI and reanalysis in improving VUS resolution.
- Share real-world approaches to managing VUS in clinical practice.
- Discuss strategies for investigating and interpreting VUS.
- Explore patient communication techniques for conveying uncertain genetic results.
- Highlight success stories where VUS were reclassified as pathogenic or benign.
Don’t miss this opportunity to engage with leading experts and peers in the field. Register today and take the next step toward resolving ambiguity in genetic diagnostics.
Do you find this post helpful?
Click the button below to copy and share the link.
3billion Inc.
3billion is dedicated to creating a world where patients with rare diseases are not neglected in diagnosis and treatment.